$390 Million is the total value of SECTOR GAMMA AS's 33 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 30.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LLY | Buy | LILLY ELI & CO | $36,456,000 | +36.1% | 724,347 | +32.8% | 9.35% | +19.7% |
| FRX | Sell | FOREST LABS INC | $34,476,000 | -6.8% | 805,700 | -10.7% | 8.84% | -18.0% |
| JNJ | Sell | JOHNSON & JOHNSON | $31,625,000 | -4.5% | 364,800 | -5.4% | 8.11% | -16.0% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $29,958,000 | -9.1% | 2,551,800 | -28.3% | 7.69% | -20.1% |
| CAH | Sell | CARDINAL HEALTH INC | $20,432,000 | +6.6% | 391,800 | -3.5% | 5.24% | -6.2% |
| BAX | Buy | BAXTER INTL INC | $19,996,000 | +12.5% | 304,400 | +18.7% | 5.13% | -1.0% |
| A | Buy | AGILENT TECHNOLOGIES INC | $14,222,000 | +124.7% | 277,500 | +87.5% | 3.65% | +97.7% |
| AUXL | Buy | AUXILIUM PHARMACEUTICALS INC | $13,867,000 | +21.8% | 761,924 | +11.3% | 3.56% | +7.1% |
| CBST | Sell | CUBIST PHARMACEUTICALS INC | $12,967,000 | -7.2% | 204,042 | -29.5% | 3.33% | -18.4% |
| ONXX | Sell | ONYX PHARMACEUTICALS INC | $12,871,000 | +14.2% | 103,215 | -20.5% | 3.30% | +0.5% |
| EW | New | EDWARDS LIFESCIENCES CORP | $12,533,000 | – | 180,000 | +100.0% | 3.22% | – |
| MDCO | Buy | MEDICINES CO | $10,671,000 | +26.3% | 318,350 | +15.9% | 2.74% | +11.1% |
| WCG | New | WELLCARE HEALTH PLANS INC | $10,384,000 | – | 148,900 | +100.0% | 2.66% | – |
| MASI | Sell | MASIMO CORP | $10,008,000 | +22.3% | 375,691 | -2.7% | 2.57% | +7.6% |
| PKI | Buy | PERKINELMER INC | $9,955,000 | +26.6% | 263,700 | +9.0% | 2.55% | +11.3% |
| TEVA | Sell | TEVA PHARMACEUTICAL INDS LTDadr | $9,947,000 | -25.1% | 263,300 | -22.3% | 2.55% | -34.2% |
| SLXP | Sell | SALIX PHARMACEUTICALS INC | $9,450,000 | -2.8% | 141,301 | -3.9% | 2.42% | -14.5% |
| LPNT | Buy | LIFEPOINT HOSPITALS INC | $8,738,000 | +21.0% | 187,400 | +26.8% | 2.24% | +6.5% |
| THOR | Buy | THORATEC CORP | $8,577,000 | +37.0% | 230,000 | +15.0% | 2.20% | +20.5% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $8,022,000 | +5.1% | 105,800 | +11.0% | 2.06% | -7.5% |
| MNKKQ | New | MALLINCKRODT PUB LTD CO | $7,892,000 | – | 179,000 | +100.0% | 2.02% | – |
| ESRX | Buy | EXPRESS SCRIPTS INC | $7,571,000 | +8.5% | 122,500 | +8.4% | 1.94% | -4.6% |
| 5100PS | New | VOLCANO CORPORATION | $7,489,000 | – | 312,700 | +100.0% | 1.92% | – |
| BIO | Buy | BIO RAD LABS INCcl a | $6,325,000 | +52.4% | 53,800 | +45.4% | 1.62% | +34.0% |
| AGN | Buy | ALLERGAN INC | $6,142,000 | +69.6% | 67,900 | +57.9% | 1.58% | +49.2% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $6,087,000 | +132.4% | 85,000 | +112.5% | 1.56% | +104.5% |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $5,008,000 | – | 422,991 | +100.0% | 1.28% | – |
| OPTR | Buy | OPTIMER PHARMACEUTICALS INC | $4,739,000 | -4.1% | 376,393 | +10.3% | 1.22% | -15.6% |
| OMI | Sell | OWENS & MINOR INC NEW | $4,392,000 | -6.9% | 126,984 | -8.9% | 1.13% | -18.0% |
| HSP | Sell | HOSPIRA INC | $2,981,000 | -65.9% | 76,000 | -66.7% | 0.76% | -70.0% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $2,879,000 | +35.4% | 36,510 | +13.0% | 0.74% | +19.2% |
| MNTA | Buy | MOMENTA PHARMACEUTICALS INC | $2,688,000 | +8.2% | 186,800 | +13.2% | 0.69% | -4.8% |
| SPPI | SPECTRUM PHARMACEUTICALS INC | $419,000 | +12.3% | 50,000 | 0.0% | 0.11% | -0.9% | |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -5,000 | -100.0% | -0.12% | – |
| DNDNQ | Exit | DENDREON CORP | $0 | – | -345,000 | -100.0% | -0.41% | – |
| SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -60,000 | -100.0% | -1.66% | – |
| RMD | Exit | RESMED INC | $0 | – | -141,770 | -100.0% | -1.87% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -131,000 | -100.0% | -2.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-12-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BOSTON SCIENTIFIC CORP | 40 | Q1 2023 | 9.9% |
| BIO RAD LABS INC | 40 | Q1 2023 | 4.7% |
| BRISTOL-MYERS SQUIBB CO | 38 | Q3 2023 | 11.9% |
| BAXTER INTL INC | 34 | Q3 2023 | 12.7% |
| CARDINAL HEALTH INC | 34 | Q3 2023 | 8.1% |
| PERKINELMER INC | 33 | Q2 2021 | 6.3% |
| BIOGEN INC | 30 | Q3 2023 | 7.6% |
| ELEVANCE HEALTH INC | 30 | Q3 2023 | 5.6% |
| GILEAD SCIENCES INC | 29 | Q3 2023 | 14.0% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 4.3% |
View SECTOR GAMMA AS's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-08-05 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-08 |
View SECTOR GAMMA AS's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.